|
|
|
Bench Mark
|
Company has acquired ISO 9001- 2000 certification from BVQI & accreditation by UKAS (UK)
Company has also been acquired with GMP (Good Manufacturing Practices) Certification from FDA Gujarat & Factory Plan fulfill, the requirement of Schedule – T Prescribed by drug authority.
Clinical studies for the products ACTIVIT, NORMACID, PEPTICARE, ENTEROCIN PEDIATRIC, HEME-CAIRE have been published in Scientific National as well as International Journals. |

|
| |
| |
ENTEROCIN PEDIATRIC SYRUP
INVITRO ANTIBACTERIAL ACTIVITY OF ENTEROCIN
PEDIATRIC
SYRUP -A POLY HERBAL ANTIDIARRHOEAL FORMULATION
Goswami J.G, Patwardhan V.D.
Abstract :
The antibacterial
activity of Enterocin Pediatric Syrup was
evaluated against E.coli, Salmonella & Shigella
at 5% and 15% concentrations of the Syrup
by agar-agar with diffusion method. Bacterial bioburden tests were conducted
which shown significant reduction in the colony count of the same. |
| |
| |
HEME CAIRE & SKIN-CAIRE
TWO INDIGENOUS COMPOSITE (HEME CAIRE & SKIN
CAIRE) IN MANAGEMENT
OF LEUCODERMA.
Dr. Avinash Shankar: MD, DNB, FRCP, PhD, MBA, and FRCGP
Chairman, R.A. Hospital & Research
Centre, Warisaliganj Nawada, Bihar, 805
130.
Dr. Madhu Shankar MD
Secretary, Leucoderma Foundation of India
East India Chapter, Ranchi, Jharkhand.
Abstract :
Leucoderma, a disease of melanin deficiency due to either altered melanin synthesis
or local dermal melanin deficiency. As non-responsive to present therapeutics,
a clinical evaluation of indigenous composite Capsule Heme Caire as Oral supplement
and Packsule Skin-Caire as topical application with Extract of MUSA SAPIENTUS
was conducted, in the patients attending the diagnostic cum treatment camps
of Leucoderma Foundation of India at Ranchi, Patna and Leucoderma Cell of RA.
Hospital and Research Centre, Warisaliganj (Nawada) reveals-
Grade 1 Clinical response to majority
cases of stage 1st , 2nd and 3rd patients
marked improvement in stage 4th, except
the patients whose continuing Psoralen
been withdrawn abruptly had initial exacerbation.
Thus the indigenous composite plays
a vital role in treatment of Leucoderma
and it is worth prescribing, at least
in fresh cases of mild to moderate cases. |
| |
| |
PEPTICAIRE CAPSULES
ANTI-ULCER ACTIVITY OF PEPTICAIRE,
A HERBOMINERAL FORMULATION
Bafna. P. A. and R. Balaraman
Department of Pharmacy, Faculty of Technology & Engineering
M.S. University of Baroda.
Abstract :
Pepticaire, a herbomineral formulation,
was tested for its anti-ulcer activity
in rats.
Effects of various doses (125,250,500 and
1000 mg/kg, p.o.) of Pepticaire were studied
on gastric mucosal injury in rats. The
reduction in ulcer index in both the models
along with the reduction in the volume
and in total acid secretion. Also an increase
in the pH of gastric fluid in pylorus –
legation rats proved the antiulcer activity
of Pepticaire. Thus it can be Concluded
that Pepticaire possesses anti-ulcer activity. |
| |
| |
ACTIVIT CAPSULES
ANTIOXIDANT ACTIVITY OF ACTIVIT ON ISOPROTERENOL
INDUCED MYOCARDIAL INFARCTION
Bafna P.A. and R.Balaraman
Department of Pharmacy, Faculty of Technology & Engineering
M. S. University of Baroda.
Abstract :
Activit, a herbomineral formulation
was tested for its antioxidant activity
in Isoproterenol induces mycordial infarction
in rats. Effects of Activit in various
doses (125, 250, 500) and 1000 mg/kg, p.o.)
was studied in animals who received isoproterenol.
The serum was estimated for creatine Kinase,
lactate dehydrogenase, uric acid, SGPT
AND SGOT. The animals were there sacrificed
and the heart was dissected out for assays
of lipid peroxidation, endogenous antioxidant
enzymes (superoxide dismutase and catalase)
and reduced glutathione (GSH). Membrane
bound enzymes (Na+K+ATPase,Ca2 ATPase,
and Mg2+ ATPase) were also estimated. It
was found that there Thus it can be Concluded
that Activit enhances antioxidant status. |
| |
| |
ASHOGYN
A CLINICAL STUDY OF ASHOGYN SYRUP IN DYSFUNCTIONAL
UTERINE
BLEEDING
Dr. Manjula Shrivastav Professor (Stri Roga)
Govt. Ayurvedic Collage, Baroda.
Abstract :
A clinical study of Ashogyn syrup
was done on 26 patients of Dysfunctional
uterine bleeding It was found that ashogyn
syrup shown a good clinical response in
patients of Dysfunctional uterine bleeding
where 17 patients were cured, 7 improved
and 2 did not shown any response. |
| |

|
|
|
|
|